Allena Pharmaceuticals, Inc. (ALNA) |
|
0.075 0.002 (3.16%)
|
09-07 16:00 |
|
Open: |
0.0641 |
Pre. Close: |
0.0727 |
|
High:
|
0.1459 |
Low:
|
0.06 |
|
Volume:
|
252,311,606 |
Market Cap:
|
0(M) |
|
|
|
Technical analysis |
as of: 2022-11-18 4:18:32 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.11 One year: 0.17 |
| Support: |
Support1: 0.01 Support2: 0.01 |
| Resistance: |
Resistance1: 0.09 Resistance2: 0.14 |
| Pivot: |
0.07 |
| Moving Average: |
MA(5): 0.07 MA(20): 0.05
MA(100): 0.08  MA(250): 0.24 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 47 %D(3): 47 |
| RSI: |
RSI(14): 80.5 |
| 52-week: |
High: 0.77 Low: 0.01 |
| Average Vol(K): |
3-Month: 68,148 (K) 10-Days: 261,996 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ALNA ] has closed below upper band by 43.3%. Bollinger Bands are 21.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.15 - 0.15 |
0.15 - 0.15 |
|
Low:
|
0.06 - 0.06 |
0.06 - 0.06 |
|
Close:
|
0.07 - 0.08 |
0.08 - 0.08 |
|
Company Description |
|
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts. |
Headline News |
Wed, 07 Sep 2022
ALLENA PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com
Tue, 06 Sep 2022
Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy - Yahoo Finance
Fri, 02 Sep 2022
ALLENA PHARMACEUTICALS, INC. : Termination of a Material ... - Marketscreener.com
Tue, 12 Jul 2022
Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split - Yahoo Finance
Mon, 21 Mar 2022
Why Are Allena Pharma Shares Plunging Today - Yahoo Finance
Sat, 08 Jan 2022
Allena Pharmaceuticals Stock: A Double [Or More] Or Kaput In The ... - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
85 (M) |
| Shares Float |
107 (M) |
|
% Held by Insiders
|
1.1 (%) |
|
% Held by Institutions
|
7.5 (%) |
|
Shares Short
|
8,590 (K) |
|
Shares Short P.Month
|
2,560 (K) |
Stock Financials |
|
EPS
|
-1.01 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.43 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
-96.1 |
|
Return on Equity (ttm)
|
-278.2 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-0.56 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-56 (M) |
|
Levered Free Cash Flow
|
-38 (M) |
Stock Valuations |
|
PE Ratio
|
-0.08 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.17 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-0.12 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
